Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Copy of the Exaimers Fax transmital of 8-13-09

Copy of the Exaimers Fax transmital of 8-13-09

posted on Aug 23, 2009 04:16PM

OSj/,13/09 THU 10:39 FAX 703 308 0758

Control No. ?&o<*$£37 1tJ<yn Ex Paife Reexaminatfon Interview Summary ao/ooBfsoe f /

Patent Under Reexamioation

*f!r

? 5809336

Examiner

Sam Rimeil

Art Unit 3992

All participants (USPTO personnel, patent owner, patent owner's representative): (1) Sam Rim&ll (3\

(2) Lam Hsruwman Date of Interview: 06 August 2009

Type: a)J3 Telephonic b)D Vide c)U Personal (copy given to:

Exhibit shown or demonstration conduct
If Yes, brief description:
_____

Agreement with respect to the claims f)E Any other agreements) are set forth be*

Claim(s) discussed: 1.2.6.7. 9-1 2 JS.1 7.1
Identification of prior art discussed: _

Description of the general nature of whar Sea Co/itfnuafton S/ieef,

(4)

:> Conference 1 )G patent owner 2)Q patent owner's representative)

sd; d)DYes e)E3 No.

3 was reached. g)D was not reached. h)D N/A. aw under "Description of the general nature of what was agreed to..."

9 and 20. : was agreed to if an agreement was reached, or any other comments:

(A fuller description, If necessary, and a copy of the amendments which the examiner agreed would render the claims patentable, if available, must be attached. Also, where no copy of the amendments that would render the claims patentable is available, a summary thereof must be attached.)

A FORMAL WRITTEN RESPONSE TO THE LAST OFFICE ACTION MUST INCLUDE PATENT OWNER'S STATEMENT OF THE SUBSTANCE OF THE INTERVIEW. (See MPEP § 2281). IF A RESPONSE TO THE LAST OFFICE ACTION HAS ALREADY BEEN FILED, THEN PATENT OWNER IS GIVEN OME MONTH FROM THIS INTERVIEW DATE TO PROVIDE THE MANDATORY STATEMENT OF THE SUBSTANCE OF THE INTERVIEW (37 CFR 1.B60(b». THE REQUIREMENT FOR PATENT OWNER'S STATEMENT CAN NOT BE WAIVED. EXTENSIONS OF TIME ARE GOVERNED BY 37 CFR 1.550fc).

/Sam Rimeil/ Primary Examiner, Art Unit 3992

cc: Requester (If third party requester)


PTOW74 (R»V. 04-01)


Ex Parts Rasxaminatlon Interview Summary


Paper No. 20090812


Received

AUGmOOB

Henneman & Associates PLC

----------------------------------------------------------------------------------------------------

Page 2

,08^3/09 THU 10:40 FAX 703 308 0758 USPTO GPOUP3300

". "' . \

Continuation Sheet (PTOL-474) Reexam Control No. 90/008,306

Continuation of Description of the general nature of what was agreed to if an agreement was reached, or any other comments: Examiner initiated Interview to indicate that proposal for claims 1,6,10 as reflected in examiner's amendment would overcome prior art of record and render claims 1,8,10 patentable, Claims 11-12,16-17,19-20 as set forth in after final response of 5/12/09 determined to overcome prior art of record. Claims previously rejected under 35 USC112 no longer presented. Further agreed on typographical correction at cot, 17, line 16, Agreed that all outstanding issues set forth in the final office action are thus resolved. Amendments to be entered by examiner's amendment. Examiner will prepare examiner's amendment and preparation of NIRC action. .

Share
New Message
Please login to post a reply